N@N

CWNR, SNNGF, STHJF, ECTE, Has Remained On Naked Short Lists 13 Consecutive Days

^{Published on 2011-02-15 06:10:23 - WOPRAI}
 

February 15, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , announced today that these select companies have been On The the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. (:CWNR), SIENNA GOLD INC (OTC:SNNGF), STRATHMORE MINERALS CORP (OTC:STHJF), ECHO THERAPEUTICS INC (OTCBB:ECTE). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.

(:CWNR) - The failure to deliver in shares of CWNR has not been resolved and a buy-in is expected.

SIENNA GOLD INC (OTC:SNNGF) - Sienna Gold Inc., an exploration stage company, engages in acquiring, exploring, and evaluating mineral properties in Peru. It principally holds mineral claims, primarily prospective for gold, comprising approximately 1,000 hectares in the District of Huaranchal, Province of Otuzco, Peru. The company was formerly known as Vortex Integrated Industrial Corporation and changed its name to Sienna Gold Inc. in April 2005. Sienna Gold Inc. was incorporated in 1987 and is headquartered in Calgary, Canada.The failure to deliver in shares of SNNGF has not been resolved and a buy-in is expected.

STRATHMORE MINERALS CORP (OTC:STHJF) - Strathmore Minerals Corporation., a resource company, engages in the acquisition, exploration, and development of uranium properties in the United States. Its principal projects include Gas Hills and Pine Tree-Reno Creek properties that are located in Wyoming; and Roca Honda property, which is located in New Mexico. The company has joint venture with Sumitomo Corp of Japan for Roca Honda property, as well as with American Uranium Corporation for Pine Tree-Reno Creek ISR project. As of December 31, 2008, it had approximately 109,340 acres of potential uranium producing lands. The company was founded in 1987 and is headquartered in Kelowna, Canada.The failure to deliver in shares of STHJF has not been resolved and a buy-in is expected.

ECHO THERAPEUTICS INC (OTCBB:ECTE) - Echo Therapeutics, Inc., a medical device and specialty pharmaceutical company, engages in developing a non-invasive, wireless, and transdermal continuous glucose monitoring (tCGM) system for use in clinical settings and for people with diabetes, as well as a range of transdermal reformulations of specialty pharmaceutical products previously approved by the United States Food and Drug Administration (FDA). The company involves in developing its needle-free Prelude SkinPrep System (Prelude) for transdermal drug delivery, including topical lidocaine; and Symphony tCGM system (Symphony), a wireless and transdermal continuous glucose monitoring system designed to provide real-time blood glucose data. Its specialty pharmaceuticals pipeline is based on AzoneTS, a nontoxic, nonirritating skin penetration enhancer to enable topical application of FDA-approved prescription medications. The companys specialty pharmaceuticals include Durhalieve, an AzoneTS formulation of triamcinolone acetonide for the treatment of corticosteroid-responsive dermatoses. It has licensing agreements with Ferndale Pharma Group, Inc. to develop, market, sell, and distribute Prelude for skin preparation prior to a range of needle-based medical procedures in North America and the United Kingdom; and Handok Pharmaceuticals Co., Ltd. for developing, marketing, selling, and distributing Symphony to medical facilities and diabetics in South Korea. The company was founded in 1989 and is based in Franklin, Massachusetts.The failure to deliver in shares of ECTE has not been resolved and a buy-in is expected.

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,750,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

Contact: Thomas Ronk / CEO www.BUYINS.net (800) 715-9999 tom@buyins.net